AMENDMENT 6 TO EMPLOYMENT AGREEMENTEmployment Agreement • February 1st, 2023 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment 6 (this “Amendment”) effective as of the 27th day of January, 2023 amends the Employment Agreement, dated July 31, 2018, as amended (the “Agreement”), by and between Adial Pharmaceuticals, Inc. (the “Company”), and William B. Stilley, III (“Executive”). Capitalized terms used herein without definition shall have the meanings assigned in the Agreement.
OPTION AGREEMENT FOR THE ACQUISITION OF PURNOVATE, INC. BY ADENOMED, LLCOption Agreement • February 1st, 2023 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations
This Option Agreement for the acquisition of the business of Purnovate, Inc. (“Option Agreement”), effective as of January 27, 2023 (the “Effective Date”), is entered into by and between Purnovate, Inc., a Delaware corporation (“Purnovate”), a wholly owned subsidiary of Adial Pharmaceuticals, Inc., a Delaware corporation (“Adial”), (Purnovate and Adial are together “Seller”) on the one hand, and Adenomed, LLC, a Virginia limited liability company (“Buyer”) on the other hand. Buyer and Seller are each a “party” and together the “parties.”
